The global health landscape faces intense pressure: aging populations, soaring costs, unequal access, and fragile supply chains. How can we spark innovation and deliver affordable solutions? In an in-depth interview with GeneOnline, Patrick Lau 刘会平, Deputy Executive Director of the Hong Kong Trade Development Council (HKTDC), shares a compelling vision, spotlighting Hong Kong’s role as a biotech and medtech powerhouse.
Hong Kong’s biotech scene is thriving, fueled by world-class medical schools at the University of Hong Kong and Chinese University of Hong Kong, led by pioneers like Nancy Ip in Alzheimer’s research. With growing government support and an FDA-like system in the works, the Greater Bay Area’s 86 million people and $2 trillion GDP offer a testing ground for solutions scalable to India, Brazil, and beyond. These breakthroughs could reshape care for aging populations in Europe and North America.
Read the full interview here: https://bit.ly/43enx7h
